Evidence map›Paper›PMID 16998359›Full record

ArticleAnnals of surgery2006

Treatment evolution in high-risk congenital diaphragmatic hernia: ten years' experience with diaphragmatic agenesis.

Kevin P Lally, Pamela A Lally, Krisa P Van Meurs, Desmond J Bohn, Carl F Davis, Bradley Rodgers, Jatinder Bhatia, Golde Dudell, Congenital Diaphragmatic Hernia Study Group

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Annals of surgery, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Defective pulmonary innervation and autonomic imbalance in congenital diaphragmatic hernia.American journal of physiology. Lung cellular and molecular physiology · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 3 countries.

Kevin P LallyDepartment of Surgery, University of Texas Medical School Houston and Memorial Hermann Children's Hospital, Houston, TX, USA. kevin.p.lally@uth.tmc.edu
Pamela A Lally
Krisa P Van Meurs
Desmond J Bohn
Carl F Davis
Bradley Rodgers
Jatinder Bhatia
Golde Dudell
Congenital Diaphragmatic Hernia Study Group
Augusta University · USCenter for Clinical Research (United States) · USEmory University · USMemorial Hermann · USRoyal Hospital for Children · GBStanford University · USUniversity of Toronto · CAUniversity of Virginia · US

Funding

Zolmitriptan challenge and human performance testingM01RR002558 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SCHULTZ, STANLEY G · 1985 to 2006
$10.3M
Advancing Clinical Research in Pediatric SurgeryK24RR017050 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LALLY, KEVIN PATRICK · 2002 to 2006
$660k
NCRR NIH HHS K24 RR017050NCRR NIH HHS K24RR17050NCRR NIH HHS M01 RR002558NCRR NIH HHS M01RR002558
6 · The paper itself

Abstract

objectiveThe objective of this study was to evaluate the impact of newer therapies on the highest risk patients with congenital diaphragmatic hernia (CDH), those with agenesis of the diaphragm. SUMMARY BACKGROUND DATA: CDH remains a significant cause of neonatal mortality. Many novel therapeutic interventions have been used in these infants. Those children with large defects or agenesis of the diaphragm have the highest mortality and morbidity.

methodsTwenty centers from 5 countries collected data prospectively on all liveborn infants with CDH over a 10-year period. The treatment and outcomes in these patients were examined. Patients were followed until death or hospital discharge.

resultsA total of 1,569 patients with CDH were seen between January 1995 and December 2004 in 20 centers. A total of 218 patients (14%) had diaphragmatic agenesis and underwent repair. The overall survival for all patients was 68%, while survival was 54% in patients with agenesis. When patients with diaphragmatic agenesis from the first 2 years were compared with similar patients from the last 2 years, there was significantly less use of ECMO (75% vs. 52%) and an increased use of inhaled nitric oxide (iNO) (30% vs. 80%). There was a trend toward improved survival in patients with agenesis from 47% in the first 2 years to 59% in the last 2 years. The survivors with diaphragmatic agenesis had prolonged hospital stays compared with patients without agenesis (median, 68 vs. 30 days). For the last 2 years of the study, 36% of the patients with agenesis were discharged on tube feedings and 22% on oxygen therapy.

conclusionsThere has been a change in the management of infants with CDH with less frequent use of ECMO and a greater use of iNO in high-risk patients with a potential improvement in survival. However, the mortality, hospital length of stay, and morbidity in agenesis patients remain significant.

Indexed as

Hernias, Diaphragmatic, CongenitalCongenital AbnormalitiesDiaphragmFemaleHernia, DiaphragmaticHumansInfant, NewbornMaleProspective StudiesRisk FactorsTime Factors

Identifiers

PMID16998359
PMCPMC1856559
OpenAlexW1555434617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.